In recent decades, Klebsiella pneumoniae has become an increasingly important nosocomial infectious agent, which is partly attributed to its increased expression of virulence factors that promote intra-hospital transmission and challenge infection control practices (1) . Additionally, strains with progressive reductions in antibacterial drug susceptibility have been isolated in different countries (2) (3) . Since the end of the 20 th century, strains have been disseminated with simultaneous resistance to various antimicrobial classes mediated by the production of extended spectrum beta-lactamases (ESBL), loss of porins, and later also by the production of carbapenemases and metallo-betalactamases (4) (5) . Development of resistances to alternative drugs used to treat hospital-acquired K. pneumoniae infections, such as polymixins and tigecycline, is currently being observed (6) .
Simultaneous and long-term analysis of K. pneumoniae susceptibility to different antimicrobials allows us to better understand current and future perspectives for the therapeutic use of these drugs. This study aimed to describe secular trends of antimicrobial susceptibility among K. pneumoniae isolates over a 14-year period in a Brazilian tertiary-care hospital.
METHODS
This is a retrospective study based on data obtained from the Microbiology Laboratory of the Ribeirão Preto Medical School Hospital at the University of São Paulo in Ribeirão Preto, Brazil. This is a public university-affiliated facility with approximately 800 active beds that provides tertiary acute care in many medical specialties for a reference population of around 3,000,000 persons. The study was performed from January 1, 2000 to December 31, 2013. During the entire study period, there was an antibiotic stewardship program actively promoted by the local Infection Control Service. This program includes weekly rounds performed by infectious disease specialists in critical areas, like intensive care units, and requires that all in-hospital antibiotic prescriptions have justification by the assistant physician of the patient, which is also audited by infectious diseases physicians. Those audits are specifically focused on the use of cephalosporins, carbapenems, β-lactamase inhibitor combinations, glycopeptides, aminoglycosides, quinolones, and polimyxins. A regularly updated guide for antimicrobial therapy
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is available for the prescribers in the hospital intranet. The Infection Control Service also promotes educational measures on the rational use of antibiotics and prevention of healthcareassociated infections.
We included all strains of K. pneumoniae isolated during the study period from any clinical specimens. To avoid the inclusion of duplicate strains, we considered only one isolate per patient in the same year. If a patient had a second infection episode apart from the first one, then, the second isolate counted as a new specimen. We did not differentiate between colonizing strains and truly infectious strains. We also did not examine if they were hospital-acquired or not. Although the vast majority of isolates included were considered hospital-acquired, a small portion of isolates was probably from community-acquired severe infections that led to the patient's admission.
We evaluated the relative frequency of K. pneumoniae isolation among all Gram-negative bacilli isolated in each analyzed period for all clinical specimens and specifically for blood cultures. The relative frequencies of Escherichia coli and Pseudomonas aeruginosa isolates in clinical samples were also estimated.
Antimicrobial susceptibility tests
These tests were performed using the automated Microscan Susceptibility tests were interpreted according to the recommendations of the Clinical Laboratory Standards Institute (CLSI, USA) over the study period (7) . The percentage of isolates susceptible to the assessed antibiotics was reported as a weighted mean for defined intervals.
Aminoglycoside minimum inhibitory concentration
The minimum inhibitory concentrations (MICs) of amikacin and gentamicin were determined using the Vitek2 TM system (Biomerieux) for K. pneumoniae isolated between January and June 2013. We selected 105 bacterial isolates obtained from blood, venous catheters, urine, surgical wounds, and deep abscesses. MIC distribution was compared between three bacterial phenotypes: a) carbapenem-resistant isolates, b) ESBLproducing carbapenem-susceptible isolates, and c) isolates with multiple susceptibilities.
Ethical considerations
This study protocol was submitted to and approved by the institutional ethics review committee (number 8718/2015). Weighted mean K. pneumoniae rates of susceptibility to various classes of antimicrobials between 2000 and 2013 are presented in Table 1 . Decreases in susceptibility to practically all antibiotics assessed were observed. Susceptibility to amikacin was maintained and even slightly increased from 2007 to 2013, exactly when a marked reduction in susceptibility to imipenem and ceftazidime occurred. Drugs that were more recently used in clinic, such as polymyxin and tigecycline, exhibited reduced in vitro activities against K. pneumoniae (Figure 2) . Susceptibilities of 90% and 55% were observed to colistin and tigecycline, respectively, in 2013. The MIC for amikacin was similar between carbapenem-resistant and ESBL-producing K. pneumoniae isolates, but both were higher than that for multi-susceptible phenotypes ( Table 2) .
The results of this study indicate a recent increase in K. pneumoniae colonization and infection of hospitalized patients, as well as a progressive reduction in the in vitro susceptibility of this Enterobacteriaceae to several antimicrobials (8) . The greater involvement of multidrug-resistant K. pneumoniae strains in hospital-acquired infectious has been simultaneously observed in Europe (9) and Asia (10) (11) . The expansion of K. pneumoniae as a colonizing and infectious agent in hospitals suggests a marked capacity of this bacterium to acquire resistance and survive in environments where antimicrobials are extensively used. A study conducted in the same hospital reported that K. pneumoniae strains expressed genes that increase resistance to carbapenems and fluoroquinolones as well as genes related to virulence factors (12) . Carbapenemase-producing K. pneumoniae that expresses genes related to capsule, fimbriae, siderophores and other virulence factors has been isolated in distinct geographic areas (1) (13) . There is evidence that K. pneumoniae has developed clones with multiple simultaneous resistance to antimicrobials and sufficient virulence to provide adaptive advantages to the hospital environment and facilitate patient colonization or infection (4) .
In the study institution, many antibiotics were introduced in the 1980s or 1990s. Since then, a continuous and variable reduction in K. pneumoniae susceptibility to these drugs has occurred. Long-term susceptibility studies have detected increasing antimicrobial drug resistance in hospitals in various countries (3) (14) . This is especially true for carbapenems. Few K. pneumoniae isolates were resistance to these antibiotics In the USA, the isolation of carbapenem-resistant K. pneumoniae has increased from <0.1% in 2002 to 4.5% in 2010, while resistance to ceftazidime has increased from 5.3% in 1999 to 11.5% in 2010 (15) . Data from the SENTRY study of intensive care units in Europe revealed a reduction in susceptibility to imipenem from 100% in 2009 to 89.7% in 2011 (16) . A multicenter study showed that resistance to imipenem increased in Brazil in 2008-2010 (8.6%) compared to 2003-2005 (1.7%) and 1997-1999 (0.5%) (17) . A rapid increase in the rate of carbapenemaseproducing K. pneumoniae isolation has been observed in Italian hospitals during a period similar to that in this study (18) . Currently, imipenem resistance rates may exceed 50% (2) .
The change made by CLSI in the carbapenem breakpoints for Enterobacteriaceae (7) may have additionally reduced the rate of isolate susceptibility to these drugs, particularly for ertapenem (19) (20) . However, the major reason for the increase in K. pneumoniae resistance to carbapenems is probably the international dissemination of bacterial clones, such as the CC11 clonal complex, which express genes that regulate the carbapenemases, including Klebsiella pneumoniae carbapenemase (KPC), oxacillinase 48 (OXA-48), and New Delhi metallo-β-lactamase (NDM) (21) (22) .
Amikacin was outstanding among antimicrobials because of its high and stable rates of K. pneumoniae susceptibility, which has allowed clinical use of this drug in infections caused by carbapenemase-producing isolates. High in vitro efficacy of amikacin has been observed in other studies (13) (16) and has been attributed to the limited clinical use of aminoglycosides over the last decades (23) . However, its higher MIC for carbapenemresistant isolates suggests that these isolates are intermediately resistant to amikacin (24) .
Polymixins and tigecycline are the major therapeutic options for treatment of infections caused by carbapenemase-producing K. pneumoniae (6) . Although polymixins were reintroduced in clinical practice a few years ago to combat multi-resistant Gram-negative bacilli, they have shown a slow and progressive reduction in activity against carbapenemase-producing K. pneumoniae, which in some studies has reached resistance rates that exceed 20% (25) (26) . Hetero-resistance to colistin, which is used more extensively, as well as the long-term therapy with polymixins are factors favoring the selection of strains resistant to these drugs (27) . The reduction in susceptibility to tigecycline occurred rapidly considering the short time for which this drug was in clinical use. This finding has also been observed in other countries (25) (28) .
This study is limited by its retrospective nature. Thus, the influence of specific events, such as outbreaks, on antibiotic susceptibility could not be precisely defined. Otherwise, the long assessment period could dilute the influence of eventual outbreaks when taking into account the long-term antimicrobial susceptibility tendencies at the institution in this study. The same idea should be considered with regard to the different methods used to assess antibiotic susceptibility. In the last eight years, the automated Vitek TM system became the only method used, and the current trend in antibiotic susceptibility is evident. Moreover, throughout the period of analysis, susceptibility results followed CLSI recommendations. Additionally, over the last 10 years, medical cases that are more complex have been admitted to the hospital, which results in an increased need for microbiological cultures and antimicrobial prescriptions. This may have contributed to the selection of resistant microorganisms, but it does not explain the specific increase in the relative frequency of K. pneumoniae isolation. Although the institution has made efforts to promote the rational use of antibiotics and prevent bacterial dissemination, these measures proved to be not effective enough. The limited number of experts in antimicrobial use hampers the audit of prescriptions. We also suspect that non-compliance with the guide for antimicrobial use is a factor that contributes to bacterial resistance.
In conclusion, our study indicates that K. pneumoniae has become a major pathogen among hospitalized patients and confirms its recent increase in antimicrobial resistance, a fact that will further complicate the clinical management of infected patients.
